Literature DB >> 29571792

Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.

Eleonora Di Campli1, Andrea Delli Pizzi2, Barbara Seccia1, Roberta Cianci1, Martina d'Annibale1, Antonella Colasante3, Sebastiano Cinalli4, Pietro Castellan5, Riccardo Navarra6, Romina Iantorno4, Daniela Gabrielli1, Angelica Buffone1, Massimo Caulo7, Raffaella Basilico1.   

Abstract

BACKGROUND: MRI plays a crucial role to identify men with a high likelihood of clinically significant prostate cancer who require immediate biopsy. The added value of DCE MRI in combination with T2-weighted imaging and DWI is controversial (risks related to gadolinium administration, duration of MR exam, financial burden, effects on diagnostic performance). A comparison of a biparametric and a standard multiparametric MR imaging protocol, taking into account the different experience of the readers, may help to choose the best MR approach regarding diagnostic performance.
PURPOSE: To determine the added value of dynamic contrasted-enhanced imaging (DCE) over T2-weighted imaging (T2-WI) and diffusion weighted imaging (DWI) for the detection of clinically significant prostate cancer, and to evaluate how it affects the diagnostic performance of three readers with different grade of experience in prostate imaging.
MATERIALS AND METHODS: Eighty-five patients underwent prostate MR examination at 1.5 T MR scanner performed because of elevated prostate-specific antigen level and/or suspicion of prostate cancer at digital rectal examination. Two MR images sets (Set 1 = biparametric, Set 2 = multiparametric) were retrospectively and independently scored by three radiologists with 7, 3 and 1 years of experience in prostate MR imaging respectively, according to PI-RADS v2. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated by dichotomizing reader scores. Receiver operating characteristic (ROC) analysis was performed and areas under the curve (AUCs) were calculated for each reader and image set. A comparison of ROC curves was performed to test the difference between the areas under the ROC curves among the three readers.
RESULTS: There was no significant difference regarding the detection of clinically significant tumor among the three readers between the two image sets. The AUC for the bi-parametric and multi-parametric MR imaging protocol was respectively 0.68-0.72 (Reader 1), 0.72-0.70 (Reader 2) and 0.60-0.54 (Reader 3). ROC curve comparison revealed no statistically significant differences for each protocol among the most experienced (Reader 1) and the other readers (Readers 2-3).
CONCLUSION: The diagnostic accuracy of a bi-parametric MR imaging protocol consisting of T2-weighted imaging and DWI is comparable with that of a standard multi-parametric imaging protocol for the detection of clinically significant prostate cancer. The experience of the reader does not significantly modify the diagnostic performance of both MR protocols.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinically significant prostate cancer; Diffusion weighted imaging; Dynamic contrasted-enhanced imaging; Multi-reader scoring; Prostate Imaging Reporting Data System version 2

Mesh:

Substances:

Year:  2018        PMID: 29571792     DOI: 10.1016/j.ejrad.2018.01.028

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  15 in total

Review 1.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

2.  Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Authors:  Daniel Junker; Fabian Steinkohl; Veronika Fritz; Jasmin Bektic; Theodoros Tokas; Friedrich Aigner; Thomas R W Herrmann; Michael Rieger; Udo Nagele
Journal:  World J Urol       Date:  2018-08-04       Impact factor: 4.226

3.  Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers.

Authors:  Stefano Cipollari; Martina Pecoraro; Alì Forookhi; Ludovica Laschena; Marco Bicchetti; Emanuele Messina; Sara Lucciola; Carlo Catalano; Valeria Panebianco
Journal:  Radiol Med       Date:  2022-09-17       Impact factor: 6.313

4.  Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?

Authors:  Serdar Aslan; Ismet Mirac Cakir; Ural Oguz; Tumay Bekci; Erhan Demirelli
Journal:  Abdom Radiol (NY)       Date:  2021-12-17

Review 5.  PI-RADSv2.1: Current status.

Authors:  Stephanie M Walker; Barış Türkbey
Journal:  Turk J Urol       Date:  2020-10-09

6.  Diagnostic Accuracy of a Rapid Biparametric MRI Protocol for Detection of Histologically Proven Prostate Cancer.

Authors:  Verena C Obmann; Shivani Pahwa; William Tabayayong; Yun Jiang; Gregory O'Connor; Sara Dastmalchian; John Lu; Soham Shah; Karin A Herrmann; Raj Paspulati; Gregory MacLennan; Lee Ponsky; Robert Abouassaly; Vikas Gulani
Journal:  Urology       Date:  2018-09-07       Impact factor: 2.649

7.  Accuracy of Prostate Magnetic Resonance Imaging: Reader Experience Matters.

Authors:  Hyunseon C Kang; Nahyun Jo; Anas Saeed Bamashmos; Mona Ahmed; Jia Sun; John F Ward; Haesun Choi
Journal:  Eur Urol Open Sci       Date:  2021-03-23

8.  Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.

Authors:  Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz
Journal:  Eur Urol Oncol       Date:  2020-03-17

9.  Usefulness of Bi-Parametric Magnetic Resonance Imaging with b=1,800 s/mm² Diffusion-Weighted Imaging for Diagnosing Clinically Significant Prostate Cancer.

Authors:  Seung Soo Lee; Dong Hoon Lee; Won Hoon Song; Jong Kil Nam; Ji Yeon Han; Hyun Jung Lee; Tae Un Kim; Sung Woo Park
Journal:  World J Mens Health       Date:  2019-07-30       Impact factor: 5.400

10.  Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.

Authors:  Lili Xu; Gumuyang Zhang; Bing Shi; Yanhan Liu; Tingting Zou; Weigang Yan; Yu Xiao; Huadan Xue; Feng Feng; Jing Lei; Zhengyu Jin; Hao Sun
Journal:  Cancer Imaging       Date:  2019-12-21       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.